Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-24

Clinical Trial Update: Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy

View source ↗

Summary

This entry provides a clinical trial update on a study investigating cognitive impairment in patients with drug-resistant and drug-responsive focal epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Epilepsy, Focal Epilepsy | Status: RECRUITING